InVivo Therapeutics Holdings CEO Richard Toselli's 2018 pay falls 44% to $742K
InVivo Therapeutics Holdings reports 2018 executive compensation
By ExecPay News
Published: November 26, 2019
InVivo Therapeutics Holdings reported fiscal year 2018 executive compensation information on November 26, 2019.
In 2018, three executives at InVivo Therapeutics Holdings received on average a compensation package of $565K, a 46% decrease compared to previous year.
Average pay of disclosed executives at InVivo Therapeutics Holdings
Richard Toselli, Chief Executive Officer, received $742K in total, which decreased by 44% compared to 2017. 60% of Toselli's compensation, or $445K, was in salary. Toselli also received $250K in bonus and $47K in other compensation.
Christopher McNulty, Chief Financial Officer, received a compensation package of $490K, which decreased by 31% compared to previous year. 72% of the compensation package, or $352K, was in other compensation.
Pamela J. Stahl, Former Chief Commercial Officer, earned $462K in 2018, a 9% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on November 26, 2019.